Canine allergy prevention

Premune aims to put a stop to the allergic scratching by offering dog owners the world’s first sustainable, preventive treatment for the most common disease among dogs.

The company originates from research in bacteriology and immunology at Sahlgrenska Academy and University of Gothenburg, with the most extensive research in infant gut bacterial flora. By early activation of the immune system, our technology is boosting natural tolerance mechanisms – preventing from future allergy development. With a new way of looking at allergies, our treatment is preventing the allergic outbreak, before it has begun.

Premune is a portfolio company of Serendipity Innovations; a venture capital firm specialized in research intensive ventures.